(Q37820803)

23 August 2017

0 references

The prognostic value of RASSF1A promoter hypermethylation in non-small cell lung carcinoma: a systematic review and meta-analysis (English)

1 reference

23 August 2017

0 references

1 reference

1 reference

1 reference

Jun Wang

1

1 reference

23 August 2017

Baocheng Wang

series ordinal

2

1 reference

23 August 2017

Xi Chen

series ordinal

3

1 reference

23 August 2017

Jingwang Bi

series ordinal

4

1 reference

23 August 2017

language of work or name

English

0 references

publication date

14 December 2010

1 reference

23 August 2017

1 reference

23 August 2017

volume

32

1 reference

23 August 2017

issue

3

1 reference

23 August 2017

page(s)

411-416

1 reference

Global cancer statistics, 2002

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ266

The International Association for the Study of Lung Cancer Staging Project: prognostic factors and pathologic TNM stage in surgically managed non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ266

The multistep nature of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ266

Role of p53 as a prognostic factor for survival in lung cancer: a systematic review of the literature with a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ266

The role of EGF-R expression on patient survival in lung cancer: a systematic review with meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ266

Has Cox-2 a prognostic role in non-small-cell lung cancer? A systematic review of the literature with meta-analysis of the survival results

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ266

RASSF6 is a novel member of the RASSF family of tumor suppressors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ266

The role of RASSF1A methylation in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ266

Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ266

Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ266

Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ266

Value of p16INK4a and RASSF1A promoter hypermethylation in prognosis of patients with resectable non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ266

DLEC1 and MLH1 promoter methylation are associated with poor prognosis in non-small cell lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ266

DNA methylation markers and early recurrence in stage I lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ266

Prognostic significance of DAPK and RASSF1A promoter hypermethylation in non-small cell lung cancer (NSCLC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ266

Methylation profiling of archived non-small cell lung cancer: a promising prognostic system

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ266

Multiplicity of abnormal promoter methylation in lung adenocarcinomas from smokers and never smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ266

RASSF1A gene inactivation in non-small cell lung cancer and its clinical implication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ266

Methylation patterns and K-ras mutations in tumor and paired serum of resected non-small-cell lung cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ266

Hypermethylation of FHIT as a prognostic marker in nonsmall cell lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ266

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ266

Beta blockade during and after myocardial infarction: an overview of the randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ266

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ266

Prognostic implication of aberrant promoter hypermethylation of CpG islands in adenocarcinoma of the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ266

Prognostic factors in non-small cell lung cancer: a decade of progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ266

Cohypermethylation of p16 and FHIT promoters as a prognostic factor of recurrence in surgically resected stage I non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ266

21 January 2018

Identifiers

DOI

10.1093/CARCIN/BGQ266

1 reference

23 August 2017

1 reference